about
Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptorPreservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53.Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis.Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function.TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.Developmental status of CD4-CD8+ and CD4+CD8- thymocytes with medium expression of CD3.Entry of CD4-CD8- immature thymocytes into the CD4/CD8 developmental pathway is controlled by tyrosine kinase signals that can be provided through TCR components.Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosisAnti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
P50
Q31031689-D65A893C-408C-41F9-B020-F3761980A43EQ38890606-C5AB6A50-DEED-4EFD-BDCD-74BBF9468C04Q39619956-3ECEB319-F4C8-48F2-8643-D5B5705D8AA3Q40126446-BF851921-26E8-412F-B5E3-1AA31C52C313Q40397252-AAD3BC9F-C98B-48DC-845F-EBFCB167140BQ40401666-5A76B3DE-5C8A-4C63-BC75-24AA2555158CQ45734015-E3D65C1C-3CF8-4FB2-A544-AE111175209EQ46462751-B487FFB7-E500-48DB-8C87-9A81804C40C3Q48503168-376B4F57-910A-4F92-AAA6-81046A092AF9Q52093456-DCA34023-64C8-42E9-B390-13E4BFB4C6DCQ52214030-2E8A6A76-9196-489E-B9D4-775A25814346Q77986128-AD7B0B1D-27F6-40CB-B048-008A0661DA6DQ91862446-2B20BB6E-794E-4821-87A3-9AC21C31D200
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael A Sheard
@ast
Michael A Sheard
@en
Michael A Sheard
@es
Michael A Sheard
@nl
type
label
Michael A Sheard
@ast
Michael A Sheard
@en
Michael A Sheard
@es
Michael A Sheard
@nl
prefLabel
Michael A Sheard
@ast
Michael A Sheard
@en
Michael A Sheard
@es
Michael A Sheard
@nl
P106
P1153
7005659055
P31
P496
0000-0002-4960-7650